跳至主要内容
临床试验/CTRI/2015/11/006385
CTRI/2015/11/006385招募中2 期

Clinical Validation study on ŪnÄnÄ« Pharmacopoeial Formulation– Zimad e Bars in Kalaf (Melasma)

Central Council for Research in Unani Medicine3 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2015年4月13日最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
300
试验地点
3
主要终点
Improvement in signs and symptoms of Zimad e Bars in Kalaf (Melasma)

研究概览

简要总结

This study is designed as a multicentric open trial in patients with **Zimad e Bars in Kalaf (Melasma)****.**After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria. The patients will be assessed clinically at baseline, 1st, 2nd, 3rd and 4th final follow ups. Each follow up will be carried out at the interval of two weeks. This includes subjective assessment of general well being and physical examination . The total duration of treatment will be eight weeks. . Laboratory parameters for safety assessment will be conducted at baseline and end of study. 

Composition of Zimaad e Baras:

S. No.

ŪnÄnÄ« Name

Botanical Name

Weight

|1.

Bekh-e-Anjeer Dashti

Ficus carica Linn.

100 g

|2.

Babchi

Psoralea corylifolia Linn.

100g

|3.

Tukhm-e-Panwar

Cleome icosandra Linn. Syn. C. viscosa Linn.

100g

|4.

Narkachoor

Zingiber zerumbet Rosc ex Smith

100g

|5

Aab-e-Lemu

Citrus limon (Linn.) Burm.f.

Q.S.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
16.00 Year(s) 至 65.00 Year(s)(—)
性别
Female

入选标准

  • Female Subjects with 18 to 65 years of age The patient presenting anyone or all signs mentioned below.
  • Ill defined light brown to grey brown macules on Forehead
  • Ill defined light brown to grey brown macules in RMR
  • Ill defined light brown to grey brown macules on Chin.

排除标准

  • Patients with anyone of the following skin disease •Bahaq Aswad (pitryasis nigra) oNamash (Naevus).
  • oBarash (lentigo) oKhÄ«lÄn (mole) oNishanate Quruh oFitzpatrick skin type grade 1 & 2 •Any systemic disorder requiring long term treatment.
  • •Drug or alcohol addict •Subjects with oral contraceptive pills (OCPs) •Pregnant and lactating woman •Those who refuse to avoid cosmetics during study period Subject Selection •Female subjects with 18 to 65 years of age •The patient presenting anyone or all signs mentioned below.
  • Ill defined light brown to grey brown macules on Forehead
  • Ill defined light brown to grey brown macules in RMR
  • Ill defined light brown to grey brown macules on Chin.

结局指标

主要结局

Improvement in signs and symptoms of Zimad e Bars in Kalaf (Melasma)

时间窗: 8 weeks

次要结局

  • Haematological and biochemical assessment for safety assessment(8 weeks)

研究者

申办方类型
Research institution

研究点 (3)

Loading locations...

相似试验